FDA Pauses Enrollment in Trials Testing Listeria as Therapy for Mesothelioma...
The U.S. Food and Drug Administration (FDA) has placed a partial hold on all clinical trials evaluating the LADD (Listeria-based immunotherapy construct) technology platform, pausing new patient...
View ArticleAduro Presents Positive Early Data from Phase 1b Mesothelioma Trial...
Combining the cancer vaccine CRS-207 with standard of care chemotherapy and cyclophosphamide looks like a promising first-line treatment for patients with unresectable malignant pleural mesothelioma,...
View Article
More Pages to Explore .....